Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The Warts Therapeutics Market?

In recent times, the market size for warts therapeutics has seen consistent growth. From $1.96 billion in 2024, it is projected to increase to $2.01 billion in 2025, with a compound annual growth rate (CAGR) of 2.6%. The factors contributing to this growth during the historic period include the usage of salicylic acid, advancements in cryotherapy, the evolution of topical treatments, surgical interventions, and the rise of immunotherapy.

In the forthcoming years, the warts therapeutics market is anticipated to witness consistent growth, projected to reach “$2.36 billion in 2029 with a compound annual growth rate (CAGR) of 4.1%. This growth during the forecast period can be related to precision medicine advancements for HPV, improvements in laser therapy, the emergence of combination therapies, the proliferation of digital health solutions, and initiatives to increase healthcare accessibility. Foreseen trends over the forecast interval encompass focused antiviral therapies, progresses in gene editing research, the advent of biodegradable delivery systems, and an emphasis on psychodermatology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11959&type=smp

Which Industry Forces Are Driving The Warts Therapeutics Market Forward?

The rising emphasis on immunizations for warts is poised to stimulate the expansion of the wart therapeutics market. Immunization involves introducing a vaccine into the body to generate antibodies to combat infections and associated diseases. Warts are a result of the human papillomavirus (HPV), and the delivery of a therapeutic or preventative vaccine against HPV inhibits wart formation. Consequently, the growing concentration on wart immunizations is enhancing the wart therapeutics market’s sales. For example, the World Health Organization, a Switzerland-based international public health entity, reported in July 2023 that there was a reduction in the count of children who didn’t receive any shots, known as zero-dose children, dropping from 18.1 million in 2021 to 14.3 million in 2022. Moreover, the global coverage for the initial dose of the HPV vaccine in girls rose from 16% in 2021 to 21% in 2022. Therefore, the increased emphasis on wart immunizations is fueling the wart therapeutics market’s growth.

How Is The Global Warts Therapeutics Market Broken Down By Segment?

The warts therapeutics market covered in this report is segmented –

1) By Type: Common Warts, Genital Warts, Flat Warts, Other Types

2) By Treatment: Physical Destruction, Immunomodulation, Chemical Destruction

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Common Warts: Typically Appear On Hands, Fingers, And Elbows, Caused By Human Papillomavirus (HPV) Types 2 And 4

2) By Genital Warts: Occur In The Genital And Anal Areas, Primarily Caused By HPV Types 6 And 11

3) By Flat Warts: Smaller And Smoother Than Common Warts, Commonly Found On The Face, Neck, And Arms

4) By Other Types: Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose), Various HPV Types Can Cause These Warts

Which Trends Are Likely To Redefine Growth Paths In The Warts Therapeutics Market?

Product innovation is increasingly becoming a trending strategy in the wart therapeutics market. To retain their standing in the market, companies in this field are advancing the development of creative treatments. For instance, in February 2023, Verrica Pharmaceuticals Inc., a dermatology therapeutics company based in the US, disclosed that its re-submitted New Drug Application (NDA) for VP-102 intended for the treatment of molluscum contagiosum, a wart type, was approved by the FDA (The United States Food and Drug Administration) and assigned a Prescription Drug User Fee Act (PDUFA) number. VP-102 is an innovation in that it’s a proprietary drug-device combo product which enables the precise topical dosing and targeted administration of cantharidin (0.7% w/v) through a single-use applicator, all in good manufacturing practices (GMP) compliant formulation.

Who Are The Global Leaders Steering The Warts Therapeutics Market Forward?

Major companies operating in the warts therapeutics market include GlaxoSmithKline plc, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Prestige Consumer Healthcare Inc., Maruho Co. Ltd, Taro Pharmaceutical Industries Ltd, Aclaris Therapeutics Inc., Novan Inc, Scholl’s Wellness Co, AIM ImmunoTech Inc., Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Nielsen BioSciences Inc., RXi Pharmaceuticals, Phio Pharmaceuticals Corp., MedCara Pharmaceuticals, KinoPharma Inc., pHion Therapeutics, Compound W, Duofilm, Curad Mediplast, Emblation Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Warts Therapeutics Market?

North America was the largest region in the warts therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the warts therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=11959&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model